120 related articles for article (PubMed ID: 25175726)
1. Severe cutaneous adverse reaction associated with vemurafenib: DRESS, AGEP or overlap reaction?
Gey A; Milpied B; Dutriaux C; Mateus C; Robert C; Perro G; Taieb A; Ezzedine K; Jouary T
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):178-9. PubMed ID: 25175726
[No Abstract] [Full Text] [Related]
2. Sarcoidosis in Patients Treated with Vemurafenib for Metastatic Melanoma: A Paradoxical Autoimmune Activation.
Lheure C; Kramkimel N; Franck N; Laurent-Roussel S; Carlotti A; Queant A; Goldwasser F; Avril MF; Dupin N
Dermatology; 2015; 231(4):378-84. PubMed ID: 26452227
[TBL] [Abstract][Full Text] [Related]
3. Early-Onset Vemurafenib-Induced DRESS Syndrome.
Munch M; Peuvrel L; Brocard A; Saint Jean M; Khammari A; Dreno B; Quereux G
Dermatology; 2016; 232(1):126-8. PubMed ID: 26418832
[TBL] [Abstract][Full Text] [Related]
4. Vemurafenib sensitivity skin reaction after ipilimumab.
Harding JJ; Pulitzer M; Chapman PB
N Engl J Med; 2012 Mar; 366(9):866-8. PubMed ID: 22375995
[No Abstract] [Full Text] [Related]
5. Vemurafenib-induced panniculitis.
Villani AP; Zaharia D; Dalle S; Depaepe L; Balme B; Thomas L
Eur J Dermatol; 2013 Apr; 23(2):258-60. PubMed ID: 23567624
[No Abstract] [Full Text] [Related]
6. Eosinophilic Infiltrates in Vemurafenib-Associated Verrucous Keratoses.
Longhurst WD; Honda K; Koon HB; Gerstenblith MR
Am J Dermatopathol; 2016 Oct; 38(10):766-8. PubMed ID: 27533075
[No Abstract] [Full Text] [Related]
7. Acne inversa-like skin lesions as a potential adverse event during vemurafenib therapy.
Thiem A; Mergler R; Kneitz H; Weyandt G; Goebeler M; Gesierich A
J Dtsch Dermatol Ges; 2016 Apr; 14(4):427-8. PubMed ID: 27027759
[No Abstract] [Full Text] [Related]
8. Granulomatous dermatitis secondary to vemurafenib in a child with Langerhans cell histiocytosis.
Chen L; Hsi AC; Kothari A; Dehner LP; Hayashi RJ; Coughlin CC
Pediatr Dermatol; 2018 Nov; 35(6):e402-e403. PubMed ID: 30216522
[TBL] [Abstract][Full Text] [Related]
9. Eccrine squamous syringometaplasia associated with vemurafenib therapy.
Story SG; Beschloss JK; Dolan CK; Thomas BC
J Am Acad Dermatol; 2012 Nov; 67(5):e208-10. PubMed ID: 23062917
[No Abstract] [Full Text] [Related]
10. Vemurafenib-induced eccrine squamous syringometaplasia.
Lescoat A; Droitcourt C; Stock N; Le Gall F; Dupuy A
Dermatology; 2013; 226(4):362-4. PubMed ID: 23860306
[TBL] [Abstract][Full Text] [Related]
11. Acneiform eruptions associated with vemurafenib.
Petukhova TA; Novoa RA; Honda K; Koon HB; Gerstenblith MR
J Am Acad Dermatol; 2013 Mar; 68(3):e97-9. PubMed ID: 23394928
[No Abstract] [Full Text] [Related]
12. Vemurafenib-induced granuloma annulare.
Lee SB; Weide B; Ugurel S; Mössner R; Enk A; Hassel JC
J Dtsch Dermatol Ges; 2016 Mar; 14(3):305-8. PubMed ID: 26972200
[No Abstract] [Full Text] [Related]
13. Vemurafenib-induced DRESS.
Wenk KS; Pichard DC; Nasabzadeh T; Jang S; Venna SS
JAMA Dermatol; 2013 Oct; 149(10):1242-3. PubMed ID: 23986488
[No Abstract] [Full Text] [Related]
14. Pyogenic granuloma as a cutaneous adverse effect of vemurafenib.
Sammut SJ; Tomson N; Corrie P
N Engl J Med; 2014 Sep; 371(13):1265-7. PubMed ID: 25251629
[No Abstract] [Full Text] [Related]
15. Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenib.
Gebhardt C; Staub J; Schmieder A; Goerdt S; Utikal J
Acta Derm Venereol; 2015 Jan; 95(1):96-7. PubMed ID: 24710689
[No Abstract] [Full Text] [Related]
16. Cumulative dermatologic toxicity with ipilimumab and vemurafenib responsive to corticosteroids.
Ludlow SP; Pasikhova Y
Melanoma Res; 2013 Dec; 23(6):496-7. PubMed ID: 24025700
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for multiple eruptive keratoacanthomas associated with vemurafenib treatment for metastatic melanoma.
Alloo A; Garibyan L; LeBoeuf N; Lin G; Werchniak A; Hodi FS; Flaherty KT; Lawrence DP; Lin JY
Arch Dermatol; 2012 Mar; 148(3):363-6. PubMed ID: 22431777
[TBL] [Abstract][Full Text] [Related]
18. Vemurafenib-induced interface dermatitis manifesting as radiation-recall and a keratosis pilaris-like eruption.
Braunstein I; Gangadhar TC; Elenitsas R; Chu EY
J Cutan Pathol; 2014 Jun; 41(6):539-43. PubMed ID: 24517243
[TBL] [Abstract][Full Text] [Related]
19. Unusual complication of vemurafenib treatment of metastatic melanoma: exacerbation of acantholytic dyskeratosis complicated by Kaposi varicelliform eruption.
Gupta M; Huang V; Linette G; Cornelius L
Arch Dermatol; 2012 Aug; 148(8):966-8. PubMed ID: 22911209
[No Abstract] [Full Text] [Related]
20. [Acantholytic dermatosis in patients treated by vemurafenib: 2 cases].
Sabatier-Vincent M; Charles J; Pinel N; Challende I; Claeys A; Leccia MT
Ann Dermatol Venereol; 2014 Nov; 141(11):689-93. PubMed ID: 25442474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
